Shenyang NovPharm Technology Co., Ltd., established in 2007, is a comprehensive pharmaceutical company specialized in the research, development, manufacturing and marketing of a broad range of APIs and high-added-value intermediates. The company owned independent R&D centers and production base. It has independently developed Febuxostat and its intermediates, Dronedarone intermediates, Agomelatine intermediates, Perindopril intermediates, Aliskiren intermediate, etc., and brought them to the market successfully. With strong research capabilities and spirit of innovation, the company has commi